Raloxifene HCL-PN*
CAS No: 82640-04-8 | IUPAC: (6-hydroxy-2-(4-hydroxyphenyl)benzo[b]thiophen-3-yl)(4-(2-(piperidin-1-yl)ethoxy)phenyl)methanone hydrochloride | Therapeutic Use: Osteoporosis | Mol.formula: C28H27NO4S | Mol.Weight: 473.59 g/mol | HSN CODE: 29349900
STRUCTURE
Product Details
- Description: Light yellow to Yellow to Green powder to crystal.
- Solubility: Freely Soluble in Methanol in Alcohol, And in Acetone; Practically Insoluble in Water
- Melting Point: 263 °C
- Assay: NLT-97.5%
- Maximum Absorption Wavelength: 286 nm
- Storage Condition: Stored in a cool, dry and ventilated place
- Type of Packing: Export worthy packing
Description
Raloxifene is used to help prevent and treat thinning of the bones (osteoporosis) only in postmenopausal women. It works like an estrogen to stop the bone loss that can develop in women after menopause, but it does not increase the bone density as much as daily 0.625 mg doses of conjugated estrogens. Raloxifene will not treat hot flashes of menopause and may cause hot flashes to occur. Also, raloxifene does not stimulate the breast or uterus as estrogen does.